Kraig Biocraft Laboratories (KBLB) Total Current Liabilities (2010 - 2026)

Kraig Biocraft Laboratories has disclosed Total Current Liabilities across 17 years of filings, most recently posting $10.9 million for Q2 2026.

• In Q2 2026, Total Current Liabilities rose 8.69% year-over-year to $10.9 million; the TTM figure through Jun 2026 stood at $10.9 million (up 8.69% YoY), while the FY2025 annual figure was $10.4 million, up 8.64% from the prior year.
• Total Current Liabilities came in at $10.9 million for Q2 2026 at Kraig Biocraft Laboratories, up from $10.4 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $10.9 million in Q2 2026 to a low of $8.1 million in Q4 2022.
• Average Total Current Liabilities over 5 years is $9.2 million, with a median of $9.1 million recorded in 2022.
• The largest YoY upside for Total Current Liabilities was 10.08% in 2023 against a maximum downside of 8.58% in 2023.
• Over 5 years, Total Current Liabilities stood at $8.1 million in 2022, then rose by 10.08% to $8.9 million in 2023, then grew by 8.2% to $9.6 million in 2024, then rose by 8.64% to $10.4 million in 2025, then climbed by 4.37% to $10.9 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $10.9 million in Q2 2026, $10.4 million in Q4 2025, and $10.2 million in Q3 2025.